Regulated Information

Seneffe - Belgium, April 30, 2013
- Eckert & Ziegler BEBIG (Euronext: EZBG; Reuters: EZBG.BR; Bloomberg: EZBG:BB) announces today that its annual financial report for the year ending December 31, 2012 is now available on the company`s website:

www.bebig.eu > Investor Relations > Financial Reports

Eckert & Ziegler BEBIG
...Contributing to saving lives!

Eckert & Ziegler BEBIG is a European-based group, active in the medical device sector of the healthcare industry.

Its core business is the treatment of cancer by brachytherapy, a special form of radiotherapy. Eckert & Ziegler BEBIG is a leader in brachytherapy in Europe and is headquartered in Belgium. It has a production facility in Germany and subsidiaries throughout Europe, as well as in India and in Brazil. Eckert & Ziegler BEBIG has also established a worldwide network of distributors and agents to support its product line.

The company's products and equipment are intended for use by oncologists, radiologists, urologists and medical physicists.

Eckert & Ziegler BEBIG employs more than 150 people. It has been listed on the Euronext stock exchange since April 1997 (Euronext: EZBG; Reuters: EZBG.BR; Bloomberg: EZBG: BB).

Contact:
Eckert & Ziegler BEBIG s.a.
Investor Relations
Tel.: +32 (0) 64 520 808
E-mail: ir@bebig.eu:
mailto:ir@bebig.eu




This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Eckert & Ziegler BEBIG via Thomson Reuters ONE

HUG#1698052

© GlobeNewswire - 2013